MBX Biosciences MBX
NASDAQ MBX
$53.93 +0.43 (+0.80%)
At close: Oct 21, 2026 · 4:00 PM EDT

MBX Biosciences (MBX) EPS (Basic) (2023 - 2026)

Updated

MBX Biosciences (MBX) reported EPS (Basic) of -$0.78 for Q2 2026, compared with -$0.58 a year earlier.

Analysis

MBX Biosciences (MBX) EPS (Basic) (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MBX Biosciences' EPS (Basic) came in at -$2.19; for FY2025, it came in at -$2.38.

  • By year, EPS (Basic) came in at -$5.82 in FY2024 and -$31.96 in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly EPS (Basic) since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$0.50 (Q1 2026), -$0.60 (Q4 2025) and -$0.63 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.30
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.68
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.62
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 MBX Biosciences 2.57 Bn 944.47 Mn - -0.78
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.78
Mar 31, 2026 -0.50
Dec 31, 2025 -0.60
Sep 30, 2025 -0.63
Jun 30, 2025 -0.58
Mar 31, 2025 -0.71
Dec 31, 2024 -1.46
Sep 30, 2024 -2.78
Jun 30, 2024 -12.62
Mar 31, 2024 -10.26
Dec 31, 2023 -8.68
Sep 30, 2023 -9.40
API Access

MBX Biosciences EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=MBX&period=max&api_key=YOUR_API_KEY